Registry Study for Talimogene Laherparepvec
Public ClinicalTrials.gov record NCT02173171. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Registry Study to Evaluate the Survival and Long-Term Safety of Subjects Who Previously Received Talimogene Laherparepvec in Amgen or BioVEX-Sponsored Clinical Trials
Study identification
- NCT ID
- NCT02173171
- Recruitment status
- Completed
- Study type
- Observational
- Phase
- Not listed
- Lead sponsor
- Amgen
- Industry
- Enrollment
- 185 participants
Conditions and interventions
Interventions
- Information collection Other
Other
Eligibility (public fields only)
- Age range
- 18 Years to 99 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Apr 26, 2010
- Primary completion
- Sep 22, 2021
- Completion
- Sep 22, 2021
- Last update posted
- Sep 29, 2021
2010 – 2021
United States locations
- U.S. sites
- 26
- U.S. states
- 18
- U.S. cities
- 26
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| University of South Alabama Mitchell Cancer Institute | Mobile | Alabama | 36604 | — |
| University of Arkansas for Medical Sciences | Little Rock | Arkansas | 72205 | — |
| St Joseph Heritage Healthcare | Santa Rosa | California | 95403 | — |
| University of Colorado Cancer Center | Aurora | Colorado | 80045 | — |
| Florida Hospital Memorial Division | Daytona Beach | Florida | 32117 | — |
| Baptist MD Anderson Cancer Center | Jacksonville | Florida | 32207 | — |
| Mount Sinai Comprehensive Cancer Center | Miami Beach | Florida | 33140 | — |
| H Lee Moffitt Cancer Center and Research Institute | Tampa | Florida | 33612 | — |
| Oncology Specialists SC | Park Ridge | Illinois | 60068 | — |
| Investigative Clinical Research of Indiana, LLC | Indianapolis | Indiana | 46260 | — |
| Allina Health System dba Virginia Piper Cancer Institute | Minneapolis | Minnesota | 55407 | — |
| Saint Louis University Hospital | St Louis | Missouri | 63110 | — |
| Morristown Medical Center | Morristown | New Jersey | 07962 | — |
| Rutgers Cancer Institute of New Jersey | New Brunswick | New Jersey | 08903 | — |
| University of North Carolina Chapel Hill | Chapel Hill | North Carolina | 27599 | — |
| Wake Forest Baptist Health Medical Center | Winston-Salem | North Carolina | 27157 | — |
| Gabrail Cancer Center, LLC | Canton | Ohio | 44718 | — |
| Providence Oncology and Hematology Care Eastside | Portland | Oregon | 97213 | — |
| Greenville Health System Institute for Translational Oncology Research | Greenville | South Carolina | 29605 | — |
| The West Clinic PC dba West Cancer Center | Germantown | Tennessee | 38138 | — |
| Henry Joyce Cancer Center | Nashville | Tennessee | 37232 | — |
| Mary Crowley Cancer Research | Dallas | Texas | 75230 | — |
| University of Texas MD Anderson Cancer Center | Houston | Texas | 77030 | — |
| Intermountain Medical Center | Murray | Utah | 84107 | — |
| University of Utah Huntsman Cancer Institute | Salt Lake City | Utah | 84112 | — |
| Wheaton Franciscan Healthcare | Franklin | Wisconsin | 53132 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 33 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02173171, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Sep 29, 2021 · Synced Jun 26, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02173171 live on ClinicalTrials.gov.